Search research articles
Contact Us
Filters
Showing results (31-40 of 149) with videos related to
Page
of 15
Sort By:
Clinical Immunology (Orlando, Fla.)
|
June 18, 2021
Improvement of renal and non-renal SLE outcome measures on sirolimus therapy - A 21-year follow-up study of 73 patients
Paramarajan Piranavan, Andras Perl
Clinical Immunology (Orlando, Fla.)
|
January 13, 2006
The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus
Gyorgy Nagy, Andras Perl
Expert Opinion on Pharmacotherapy
|
June 10, 2009
Pharmacotherapy of systemic lupus erythematosus
Lisa Francis, Andras Perl
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 2014
Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus
Hiroshi Kato, Andras Perl
Current Opinion in Rheumatology
|
March 29, 2019
Pathogenesis and treatment of autoimmune rheumatic diseases
Eric Liu, Andras Perl
Discovery Medicine
|
March 31, 2010
mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?
David Fernandez, Andras Perl
Antioxidants & Redox Signaling
|
May 26, 2021
Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity
Akshay Patel, Andras Perl
Autoimmunity Reviews
|
February 26, 2025
Cell type-specific regulation of the pentose phosphate pathway during development and metabolic stress-driven autoimmune diseases: Relevance for inflammatory liver, renal, endocrine, cardiovascular and neurobehavioral comorbidities, carcinogenesis, and aging
Katalin Banki, Andras Perl
Trends in Immunology
|
May 10, 2018
Metabolism as a Target for Modulation in Autoimmune Diseases
Nick Huang, Andras Perl
International Journal of Molecular Sciences
|
July 14, 2023
Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4<sup>+</sup> T Cells-Implications for the Pathogenesis of Systemic Lupus Erythematosus
Joy S Park, Andras Perl
Page
of 15
Search research articles
Search
Showing results (31-40 of 149) with videos related to
Sort By:
Page
of 15
Clinical Immunology (Orlando, Fla.)
|
June 18, 2021
Improvement of renal and non-renal SLE outcome measures on sirolimus therapy - A 21-year follow-up study of 73 patients
Paramarajan Piranavan, Andras Perl
Clinical Immunology (Orlando, Fla.)
|
January 13, 2006
The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus
Gyorgy Nagy, Andras Perl
Expert Opinion on Pharmacotherapy
|
June 10, 2009
Pharmacotherapy of systemic lupus erythematosus
Lisa Francis, Andras Perl
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 2014
Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus
Hiroshi Kato, Andras Perl
Current Opinion in Rheumatology
|
March 29, 2019
Pathogenesis and treatment of autoimmune rheumatic diseases
Eric Liu, Andras Perl
Discovery Medicine
|
March 31, 2010
mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?
David Fernandez, Andras Perl
Antioxidants & Redox Signaling
|
May 26, 2021
Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity
Akshay Patel, Andras Perl
Autoimmunity Reviews
|
February 26, 2025
Cell type-specific regulation of the pentose phosphate pathway during development and metabolic stress-driven autoimmune diseases: Relevance for inflammatory liver, renal, endocrine, cardiovascular and neurobehavioral comorbidities, carcinogenesis, and aging
Katalin Banki, Andras Perl
Trends in Immunology
|
May 10, 2018
Metabolism as a Target for Modulation in Autoimmune Diseases
Nick Huang, Andras Perl
International Journal of Molecular Sciences
|
July 14, 2023
Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4<sup>+</sup> T Cells-Implications for the Pathogenesis of Systemic Lupus Erythematosus
Joy S Park, Andras Perl
Page
of 15